Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Exogene Logo

Exogene focuses on the discovery of novel tumour targets shared across patients and safe and effective target-specific TCRs.

Their artificial intelligence platform rapidly screens billions of TCRs from patients in order to computationally identify rare TCRs that can target and destroy cancer cells. The AI learns from the billions of interactions between TCR and cancer cells that Exogene analyses at their labs using a range of cutting edge screening techniques.

 

Founders

Federico Paoletti - CEO and Co-Founder

A computational biologist with deep expertise in mathematical modelling and molecular biophysics. 

 

Andrea Mambrini - CTO and Co-Founder

An experienced Machine Learning Scientist.

 

 

We are truly excited by the opportunity to work at the BioEscalator alongside some of the most exciting and promising biotechnology companies in the world. We believe that joining the stimulating environment at the BioEscalator will help Exogene achieve its goals to discover highly effective cell therapies for solid tumours using machine learning.

Dr Federico Paoletti - CEO and Co-Founder

Click here to visit Exogene's website